Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.48M Sell
6,843
-183
-3% -$62.6K 0.72% 30
2026
Q1
$2.47M Sell
7,026
-3
-0% -$1.07K 0.79% 27
2025
Q4
$2.3M Buy
7,029
+5,032
+252% +$1.6M 0.84% 26
2025
Q3
$564K Sell
1,997
-5,128
-72% -$1.49M 0.24% 50
2025
Q2
$1.99M Sell
7,125
-4,997
-41% -$1.42M 0.92% 24
2025
Q1
$3.78M Buy
12,122
+4
+0% +$1.18K 1.87% 15
2024
Q4
$3.16M Sell
12,118
-230
-2% -$68.2K 1.59% 16
2024
Q3
$3.98M Buy
12,348
+103
+0.8% +$33.7K 1.96% 14
2024
Q2
$3.83M Buy
12,245
+4
+0% +$1.18K 1.97% 14
2024
Q1
$3.48M Buy
12,241
+2
+0% +$585 1.82% 16
2023
Q4
$3.53M Buy
12,239
+2
+0% +$545 2.22% 13
2023
Q3
$3.29M Buy
12,237
+2
+0% +$499 2.27% 13
2023
Q2
$2.72M Sell
12,235
-341
-3% -$79.1K 1.82% 13
2023
Q1
$3.04M Buy
12,576
+5
+0% +$1.23K 2.06% 12
2022
Q4
$3.3M Sell
12,571
-25
-0.2% -$6.7K 2.42% 12
2022
Q3
$2.84M Sell
12,596
-31
-0.2% -$7.51K 2.31% 13
2022
Q2
$3.07M Buy
12,627
+42
+0.3% +$10.3K 2.53% 10
2022
Q1
$3.04M Sell
12,585
-38
-0.3% -$8.73K 2.6% 11
2021
Q4
$2.84M Buy
+12,623
New +$2.66M 2.3% 10

Other funds holding AMGN

Nova R Wealth's AMGN Position: Q2 2026 in Review

Nova R Wealth reduced its Amgen (AMGN) stake by 2.6% in Q2 2026, selling an estimated $62.6K and leaving 6,843 shares worth $2.48M. The position accounts for 0.72% of the portfolio, ranked #30.

Nova R Wealth first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.98M in Q3 2024. 679 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Nova R Wealth held 6,843 shares of Amgen worth $2.48M as of Q2 2026.
  • Nova R Wealth sold 183 Amgen shares in Q2 2026, an estimated $62.6K.
  • Amgen made up 0.72% of Nova R Wealth's portfolio in Q2 2026, its #30 holding.
  • Nova R Wealth first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
  • Nova R Wealth's Amgen position peaked at $3.98M in Q3 2024.
  • 679 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Nova R Wealth's 13F filing for Q2 2026, filed 17 Jul 2026.